A Comparative Study of Using Scorpion Antivenom Versus Scorpion Antivenom and Prazosin
Status:
RECRUITING
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Interventional study designed for the evaluation of characters and the outcome of scorpion sting patients will admit to Sohag University Hospitals in 2 randomized groups. The first group will receive scorpion antivenom only whether by the intravenous or the intramuscular route of administration. The second group will receive a combination of prazosin plus scorpion antivenom whether by the intravenous or the intramuscular route of administration. Both groups will receive proper first aid and supportive treatment